Premenstrual Dysphoric Disorder Awareness and Research Act of 2026

This bill directs the National Institutes of Health to expand research into Premenstrual Dysphoric Disorder, a severe mood and physical condition affecting 5 to 8 percent of women and people assigned female at birth. It requires the agency to collect data on PMDD prevalence, economic impact, and treatment barriers while ensuring diverse populations are included in studies. The legislation also funds public awareness campaigns and grants to train healthcare professionals in diagnosing and treating the condition. Additionally, the bill mandates a report to Congress within two years detailing progress on research, education, and access to care.